Skip to main content

Asmanex Twisthaler Side Effects

Generic name: mometasone

Medically reviewed by Drugs.com. Last updated on Dec 18, 2023.

Note: This document contains side effect information about mometasone. Some dosage forms listed on this page may not apply to the brand name Asmanex Twisthaler.

Applies to mometasone: implantation implant. Other dosage forms:

Serious side effects of Asmanex Twisthaler

Along with its needed effects, mometasone (the active ingredient contained in Asmanex Twisthaler) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking mometasone:

More common

Less common

Incidence not known

For Healthcare Professionals

Applies to mometasone: inhalation aerosol, inhalation aerosol powder.

Gastrointestinal

In clinical trials, gastroenteritis and vomiting occurred with an incidence of at least 1% but less than 3%.[Ref]

Very common (10% or more): Oral candidiasis

Uncommon (0.1% to 1%): Dry mouth and throat, dyspepsia[Ref]

Nervous system

Very common (10% or more): Headache[Ref]

Respiratory

Very common (10% or more): Nasopharyngitis, allergic rhinitis, upper respiratory infection

Common (1% to 10%): Sinusitis, bronchitis, pharyngitis, dysphonia, epistaxis, nasal irritation, respiratory disorder

Postmarketing reports: Asthma aggravation, which may include cough, dyspnea, wheezing and bronchospasm[Ref]

Genitourinary

Common (1% to 10%): Dysmenorrhea, urinary tract infection (in pediatrics)[Ref]

Musculoskeletal

Common (1% to 10%): Musculoskeletal pain, back pain, myalgia[Ref]

Other

In clinical trials, fatigue, flu-like symptoms, pain, earache, and infection occurred with an incidence of at least 1% but less than 3%.[Ref]

Common (1% to 10%): Fatigue, flu-like symptoms, pain, earache, infection, fever and bruise (in pediatrics)[Ref]

Cardiovascular

Uncommon (0.1% to 1%): Palpitations[Ref]

Metabolic

Uncommon (0.1% to 1%): Weight increase[Ref]

Ocular

Rare (less than 0.1%): Glaucoma, cataracts

Postmarketing reports: Vision blurred[Ref]

Psychiatric

Frequency not reported: Psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression[Ref]

Hypersensitivity

Postmarketing reports: Immediate and delayed hypersensitivity reactions including rash, pruritus, angioedema and anaphylactic reaction[Ref]

Frequently asked questions

References

1. Product Information. Asmanex Twisthaler (mometasone). Schering-Plough Corporation. 2005.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

3. Product Information. Asmanex HFA (mometasone). Merck & Co., Inc. 2014.

4. US Food and Drug Administration. Drug Safety Label Changes (SLC): Asmanex HFA. https://www.accessdata.fda.gov/scripts/cder/safetylabelingchanges/index.cfm?utm_campaign=SLC%203%2F30&utm_medium=email&utm_source=Eloqua&event=searchdetail.page&DrugNameID=329&elq 2018.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.